Investment area

Growth Investments

Bioindustrial Investments


North America

Date of investment

April 2019

MycoWorks is a San Francisco-based materials company focused on the development and manufacturing of sustainable products. The company’s first product, Reishi ™, is the first non-plastic, non-animal material that performs like leather.

Visit site


Stephen van Helden


Departments: Growth Investments, Novo Holdings Equity US Inc., Bioindustrial Investments

Stephen joined Novo Holdings in 2022.

Prior to joining Novo Holdings, Stephen spent over 5 years developing new products, partnerships and businesses at The Production Board as an EIR, and Zymergen where he led many Industrial efforts including across Agriculture, Food and Packaging. He previously worked with McKinsey and Company as an Associate Partner across a number of sectors and geographies.

Stephen holds an MBA from Stanford University and a BSc in Electrical Engineering from the University of Cape Town.


Anders Bendsen Spohr

Senior Partner, Head of Bioindustrial Investments

Departments: Bioindustrial Investments, Life Sciences Operating Committee

Anders joined Novo Holdings A/S in 2017.
Anders is Sr Partner and Head of the Bioindustrial investments team.

Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.

Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.